TITLE:
Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)

CONDITION:
Fatty Liver

INTERVENTION:
Metformin

SUMMARY:

      The purpose of this study is to determine if therapeutic modification of insulin resistance
      or oxidative stress leads to improvement in serum or histologic indicators of liver injury
      or quality of life.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 8 Years to 17 Years
Criteria:

        -  Age 8-17 years at first screening visit

          -  Histologic evidence of Nonalcoholic Fatty Liver Disease (NAFLD) - biopsy cannot be
             older than 6 months as of randomization

          -  ALT level >60 U/L at time of screening and on one previous occasion determined at
             least one month but no greater than 6 months prior to screening ALT

          -  Consent
      
